Oragenics-Intrexon Collaboration Announces Significant Progress Towards Commercial Production of Lead Lantibiotic MU1140 February 12, 2013
Oragenics Receives European Union CPNP Notifications for ProBiora3® Cosmetic Tablets February 11, 2013
Oragenics CEO To Present at The BIO CEO & Investor Conference on February 12th 2013 February 11, 2013
Oragenics Announces New Strategic Partnership with Japanese-Based Company, Organic Wave, Inc. dba KYB America January 22, 2013
Oragenics Announces New Strategic Partnership with Mexico-Based Company, Pharmacos Exakta, S.A. de C.V. November 14, 2012
Oragenics Announces New Trading Symbol “OGEN” and Trading of Shares on Both the OTCQB and OTCBB September 25, 2012
